Kuvaus

Sobril (Oxazepam) – Benzodiazepine Anxiolytic (Rx, Controlled Medicine)

Sobril (oxazepam) is a benzodiazepine-class anxiolytic used for the treatment of anxiety disorders, tension states, and alcohol withdrawal symptoms. It acts by enhancing the effect of gamma-aminobutyric acid (GABA) in the central nervous system, producing calming, sedative, muscle-relaxant, and anxiolytic effects.

Oxazepam is considered a short-to-intermediate acting benzodiazepine, often preferred in certain patients (such as elderly or those with liver impairment) because it is metabolized through direct glucuronidation, which is less dependent on liver oxidation pathways.

Tärkeimmät tiedot

• Active Ingredient: Oxazepam
• Drug Class: Benzodiazepine
• Käyttöaiheet:
  • Generalized anxiety disorder
  • Short-term anxiety relief
  • Alcohol withdrawal symptoms
• Mechanism of Action: Enhances GABA-A receptor activity → CNS inhibition
• Onset of Action: ~30–60 minutes
• Duration of Action: ~6–12 hours
• Prescription Status: Controlled prescription medicine

Määrittelyt

• Dosage Forms: Oral tablets
• Common Strengths: 10 mg, 15 mg, 25 mg
• Hallinto: Suun kautta
• Half-Life: ~5–15 hours (variable)
• Metabolism: Hepatic via glucuronidation (no active metabolites)
• Poistuminen: Munuaisperäinen
• Varastointi: Huoneenlämpö

Annostus ja antotapa

• Initial dose: Low dose, adjusted based on response
• Typically taken 2–4 times daily depending on indication
• Short-term use is generally recommended
• Gradual tapering required when discontinuing

Yhteensopivuus / Soveltuvuus

• Patients with anxiety or tension disorders
• Individuals undergoing alcohol withdrawal management
• Often preferred in elderly patients or those with liver impairment
• Vaatii lääketieteellistä valvontaa

Vasta-aiheet

• Severe respiratory insufficiency
• Sleep apnea syndrome
• Severe liver impairment (use caution even though metabolism is safer)
• Hypersensitivity to benzodiazepines
• Acute alcohol intoxication with CNS depression

Why Choose Sobril?

Sobril (oxazepam) is a well-established benzodiazepine option for managing anxiety and alcohol withdrawal symptoms, often chosen for its predictable metabolism and suitability in certain patient groups, including those with reduced liver function.